Home » Topics » Regulatory

Regulatory
RSS

FDA approves Diacomit for seizures associated with Dravet syndrome

Aug. 24, 2018

FDA approves Takhzyro for prevention of HAE attacks

Aug. 24, 2018

Ono announces new Japanese approvals for Opdivo

Aug. 22, 2018

Lenvatinib approved in the U.S. for unresectable hepatocellular carcinoma

Aug. 17, 2018

Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months

Aug. 16, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval

Aug. 13, 2018

FDA approves Arakoda for prevention of malaria

Aug. 10, 2018

Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia

Aug. 10, 2018

FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma

Aug. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...